Zepbound Canada guide: approval, cost by dose, the savings card and coverage

Zepbound Canada approval: what Health Canada authorized

Zepbound in Canada is Eli Lilly’s weekly tirzepatide pen for weight loss, and it is a fully authorized, marketed drug here, not a US import. Health Canada issued its notice of compliance on May 13, 2025 (NOC 35344)¹. Lilly announced that it was in Canadian pharmacies on July 9, 2025⁹, and the Drug Product Database shows the same first market date².

The original name was “Zepbound KwikPen.” Health Canada changed the product name to plain “Zepbound” on February 12, 2026¹.

You may still see both names on boxes, receipts and insurance forms. They are the same product.

The Canadian monograph lists two uses³:

• Chronic weight management, meaning weight loss and keeping it off, in adults with a BMI of 30 or more, or a BMI from 27 up to 30 with at least one weight-related health problem.
• Moderate to severe obstructive sleep apnea in adults who also have obesity. This use was added on June 11, 2026¹, and Lilly called it the first sleep apnea medicine in Canada for adults living with obesity¹⁰.

Zepbound has no Canadian label for anyone under 18³.

Zepbound DIN numbers in Canada

Each Zepbound strength has its own eight-digit Drug Identification Number (DIN). All six were listed as marketed when we checked the Drug Product Database on November 12, 2026².

Zepbound strength (per weekly dose)	DIN	Status
2.5 mg	02557509	Marketed
5 mg	02557517	Marketed
7.5 mg	02557525	Marketed
10 mg	02557533	Marketed
12.5 mg	02557541	Marketed
15 mg	02557568	Marketed

Every Zepbound KwikPen holds four weekly doses of one strength, so one pen lasts about a month³. If a box you are handed does not show one of these numbers, stop and ask the pharmacist. Health Canada tells buyers to look for the DIN on the label and look it up in the Drug Product Database^11,12.

What the sleep apnea approval means

If you snore, stop breathing at night and live with obesity, Zepbound is the one weight-loss drug in Canada with a sleep apnea label¹⁰. The approval rests on two 52-week trials, SURMOUNT-OSA-1 and SURMOUNT-OSA-2, which together enrolled 469 adults with moderate to severe sleep apnea and obesity³.

People in the first trial were not using a CPAP-style breathing machine. People in the second trial were.

Here is what the Canadian monograph reports after a year on 10 or 15 mg³:

• Breathing pauses per hour (the apnea-hypopnea index) fell by 25.3 on Zepbound against 5.3 on placebo in the first trial, and by 29.3 against 5.5 in the second.
• Remission or mild sleep apnea without daytime sleepiness was reached by 42.2% on Zepbound against 15.9% on placebo in the first trial, and 50.2% against 14.3% in the second.
• Body weight dropped 17.7% and 19.6% on Zepbound, against 1.6% and 2.3% on placebo.

One caution from the label: Zepbound does not replace a breathing machine for people who need one. Any change to that therapy is your doctor’s call³.

How much is Zepbound in Canada?

Lilly’s Canadian list price is $300 for a 4-week pen at the 2.5 and 5 mg doses, $420 at 7.5 and 10 mg, and $540 at 12.5 and 15 mg⁴. The Globe and Mail reported those prices on December 17, 2025, from a note Lilly sent to pharmacies, and said the cut was 20 per cent or more and took effect on December 29⁴. Reuters carried the same report the same day, with the same lower two tiers⁵.

You will not pay the list price at the counter. The pharmacy adds its markup and a dispensing fee. Our price data runs those steps for every province and chain, and this is what it gives for one pen, before insurance⁶:

Zepbound cash price in Canada, one 4-week pen, by dose tier

Brand (use in Canada)	Dose	What you get	Cash price	Basis
Zepbound (weight)	2.5 or 5 mg	1 pen, 4 weekly doses	$314–418	Estimated
Zepbound (weight)	7.5 or 10 mg	1 pen, 4 weekly doses	$439–581	Estimated
Zepbound (weight)	12.5 or 15 mg	1 pen, 4 weekly doses	$563–742	Estimated

Read the table with two warnings in mind:

1. Every Zepbound row is estimated. It is modelled from the list price, a pharmacy markup and each chain’s fee. No retail audit of Zepbound prices exists in our data yet⁶.
2. The top of each range is the worst case. The $742 figure at 12.5 and 15 mg is the dearest province and chain combination in the model, not what a typical buyer pays. At the low end of the dose ladder, think “from about $314 a pen.”

Fees differ by chain too: Costco charges the least in that data ($4.49) and Shoppers the most ($13.99) of the store chains⁶. A quick phone call to two or three pharmacies near you is worth the five minutes.

Zepbound cost without insurance, by dose stage

Your Zepbound bill depends on where you are on the dose ladder, and it can rise after the first two pens. The Canadian monograph sets the climb: 2.5 mg a week for the first 4 weeks, then 5 mg, then more in 2.5 mg steps after at least 4 weeks on each dose, up to a maximum of 15 mg³.

For weight management, the usual maintenance doses are 5, 10 or 15 mg. For sleep apnea, they are 10 or 15 mg³.

So the first two pens, at 2.5 mg and then 5 mg, both sit in the cheapest tier. If your prescriber keeps you at 5 mg, the price stays there.

A move to 7.5 mg or higher puts you in a dearer tier. Your prescriber sets the dose, not the price list, and we are quoting the label here, not advising on dosing.

For a full-year view, Canada’s Drug Agency worked out the cost at Lilly’s submitted prices: $3,913 to $7,044 per patient per year, depending on the dose⁸. Those figures use Lilly’s price, so a pharmacy’s markup and dispensing fee would come on top at the counter.

Is there a Zepbound savings card in Canada?

Yes, Lilly offers one through its own patient programme, but Lilly’s Canadian page does not say how much it saves. The programme is called the myzepbound Savings and Support Program. Lilly Canada lists three parts¹³:

• a savings card, offered whether or not you have insurance;
• help with private insurance, including the forms your plan may ask for;
• free digital resources for getting started.

The fine print on that page says exclusions and exceptions may apply, the services are for Canadian residents only, and the programme can change¹³. You sign up on Lilly’s myzepbound website once you have a prescription. Questions go to the programme line at 1-833-382-8639, Monday to Friday, 8 a.m. to 8 p.m. Eastern¹³.

We could not confirm a dollar figure for the card from a page we were able to read, so we do not quote one. Ask the programme what your price would be at your dose, with and without your plan, before you count on it.

Two traps to skip. Lilly’s Canadian programme is the one built for Canadian residents¹³, so a savings card you find on a US website is a different offer.

And be wary of coupon or “discount card” sites promising a Canadian Zepbound deal. We could not verify any of them, so we link to none.

Does insurance or a provincial plan cover Zepbound?

For most Canadians, a public plan will not pay for Zepbound for weight loss: as of November 2026 we found no province that lists it for that use, and private coverage depends on your plan. Canada’s Drug Agency (CDA-AMC) published its recommendation on August 28, 2026. The verdict was “reimburse with conditions,” with a narrow group in mind⁸.

The agency’s committee found Zepbound did not show acceptable clinical value for everyone on its label when weighed against diet and activity alone, or against semaglutide. It did see enough value in one subgroup: adults with a BMI of 27 or more who have prediabetes⁸. In that group’s trial data, Zepbound also slowed the move to type 2 diabetes over 176 weeks⁸.

If a province follows the advice, coverage would look like this⁸:

• Who: adults with a BMI of 27 or more, prediabetes, and at least one diet attempt that did not work, by their own report.
• How prediabetes is shown: one A1C result of 5.7% to 6.4%, two fasting glucose tests of 5.6 to 6.9 mmol/L on separate days, or a two-hour glucose test of 7.8 to 11.0 mmol/L.
• Staying on it: proof of at least 5% weight loss from the start after year one, then a check every year.
• Not with: another GLP-1 drug at the same time.
• Price: it must come down. Measured against the agency’s value bar of $50,000 per year of good-quality life gained, its analysis called for a cut of 25% to 49%.

The agency also put the likely cost to public plans at about $2.4 billion over the first three years for the prediabetes group alone⁸. Our read: a bill that size makes provinces cautious. A recommendation is advice, not a listing, and each plan decides after price talks.

Private and workplace plans

Lilly’s programme offers help with private insurance forms and with understanding what your plan covers¹³. Call your insurer with the drug name and DIN in hand and ask whether weight management drugs are covered at all, whether there is a prior authorization step, and what share you would pay. Our weight loss injections guide covers how plans treat the other weight brands.

How to get Zepbound in Canada

You need a prescription from a licensed prescriber and a licensed Canadian pharmacy to fill it. The steps:

1. Check that the label fits you. A BMI of 30 or more, or 27 to under 30 with a weight-related condition, or moderate to severe sleep apnea with obesity³.
2. Book a prescriber. Your family doctor or nurse practitioner, a walk-in clinic, or a licensed Canadian online clinic that does a real assessment.
3. Check your coverage before the first fill. Use the DIN for your starting strength (02557509 for 2.5 mg) when you call your insurer².
4. Enrol in Lilly’s programme if you want the savings card or help with insurance forms¹³.
5. Fill it at a licensed pharmacy. Health Canada says only licensed pharmacies can legally sell prescription drugs here¹².

We do not name or rank clinics. Our guide to getting a weight loss injection in Canada has a checklist for vetting an online clinic.

What your prescriber will go over

A few points from the Canadian monograph tend to come up at the first visit³:

• The pill. If you use oral birth control, the label advises switching to a non-oral method, or adding a barrier method, for 4 weeks after you start and for 4 weeks after each dose increase.
• Your gallbladder. In three weight trials, gallbladder inflammation showed up in 0.6% of people on Zepbound against 0.2% on placebo.
• Your pancreas and thyroid. The label warns about pancreatitis and about thyroid C-cell tumours seen in rats, so expect questions about your history.
• Storing the pen. Keep it in the fridge at 2°C to 8°C. If needed, one pen can stay out of the fridge at up to 30°C for up to 30 days, which helps when you travel.

Is there a generic Zepbound in Canada?

No. There is no generic tirzepatide in Canada, and none is in the pipeline that Health Canada publishes.

The only tirzepatide products in the Drug Product Database are Lilly’s own Zepbound and Mounjaro². Health Canada’s list of generic submissions under review, current as of September 30, 2026, shows no generic tirzepatide at all⁷.

That makes Zepbound different from semaglutide, where cheaper generic pens have already reached Canadian shelves for diabetes². If you see “generic Zepbound” or loose “tirzepatide vials” for sale in Canada, it is not an authorized product. Health Canada warned in January 2026 that some retailers, in stores and online, were selling unauthorized GLP-1 drugs, and that fakes may hold too much, too little or none of the drug¹².

Zepbound vs Mounjaro in Canada

Zepbound and Mounjaro are the same drug in different boxes. Both are tirzepatide from Eli Lilly, sold as KwikPens in the same six strengths. The difference is the label, and that difference shapes who pays.

	Zepbound	Mounjaro
Drug	tirzepatide	tirzepatide
Authorized in Canada for	Weight management; sleep apnea with obesity	Type 2 diabetes (adults, and children 10 to under 18)
Lilly list price per 4-week pen	$300 / $420 / $540 by dose tier	Same as Zepbound
Price basis in our data	Estimated	Audited at 3 chains, rest estimated

The label facts come from the two monographs^3,14. The Globe and Mail reported that Lilly’s December 2025 cut set the same list prices for both brands⁴. The basis labels come from our price data⁶.

What this means for you:

• Using Mounjaro for weight is off-label. A doctor can still prescribe it that way, but Health Canada reviewed it only for diabetes¹⁴.
• A drug plan may cover one and not the other. Plans often treat diabetes drugs and weight-loss drugs under different rules, so the same molecule can cost you very different amounts.
• The pharmacy prices look a little different on paper, because Mounjaro’s come partly from a store audit and Zepbound’s come from a model, not because the list prices differ.

How well does tirzepatide work? In SURMOUNT-1, adults without diabetes lost 15.0%, 19.5% and 20.9% of their weight on 5, 10 and 15 mg over 72 weeks, against 3.1% on placebo¹⁵.

Weight-loss peptides compared on trial results, time to effect, how you take them, Canadian price, Health Canada status and evidence grade

Peptide	Weight loss	Time to full effect	How you take it	Cost per month	Health Canada	Grade
TirzepatideZepbound, Mounjaro	−20.9%SURMOUNT-1 · 72 wk · n=2,539	~17 moFull dose after 20 weeks	EasyWeekly pen	$314–742Cash, before insurance	Approved (Zepbound)	A

Best result = average weight loss at the highest dose in each drug's own main trial, so rows from different trials are not a head-to-head test. Cash prices in CAD before insurance; US prices in US dollars are shown only for drugs not sold here.How we grade

For the head-to-head trial against semaglutide, read our Mounjaro vs Ozempic breakdown. For how it stacks up against Wegovy as a weight brand, see Zepbound vs Wegovy. Our ranking of GLP-1 drugs puts all the options in one place.

Fake Zepbound and “research” tirzepatide

Buy Zepbound only from a licensed pharmacy with a prescription. Tirzepatide is one of the drugs Health Canada keeps finding in illegal products.

It was on the list of peptides seized from a seller called “Canada Peptide” in August 2025¹⁶. In November 2026, Health Canada warned about contaminated, unauthorized injectable peptides sold by two Canadian websites, and tirzepatide was on that advisory’s product list¹⁷.

If you already used something that may not be genuine, Health Canada’s advice is to talk to a health professional¹². Our page on whether peptides are legal in Canada explains the law and the recent seizures.

How we checked this page

We built this Zepbound Canada guide from public records and read each one ourselves. We looked up every Zepbound DIN and its status in Health Canada’s Drug Product Database, and every approval date in the Notice of Compliance database, on November 12, 2026^2,1. The indications, dose steps, warnings, storage rules and sleep apnea results are quoted from the Canadian monograph³.

List prices come from the Globe and Mail and Reuters reports, which we read ourselves, and match the prices Lilly submitted to Canada’s Drug Agency^4,5,8. Pharmacy prices come from one pricing dataset, and every Zepbound row in it is estimated⁶. The savings programme section uses only what Lilly Canada publishes¹³.

Nobody on our team took Zepbound for this guide, and no pharmacist has reviewed it yet, so the page shows “Pharmacist review pending” until one does. Our grading method explains how we score the evidence, and the peptide rankings on our home page show where tirzepatide sits among the rest.

Your next step with Zepbound

If your BMI or sleep apnea puts you within the Canadian label, book a prescriber visit, then call your insurer and Lilly’s programme with the DIN for your starting dose before the first fill. Budget from about $314 a pen at the starting doses, and plan for the price to rise if your dose does.

Not sure Zepbound is the right fit? Take the one-minute quiz to compare it with the other options.